Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

Eur J Endocrinol. 2017 Mar;176(3):X1. doi: 10.1530/EJE-15-1017e.

Authors

Lars Sävendahl¹, Effie Pournara², Birgitte Tønnes Pedersen³, Oliver Blankenstein⁴

Affiliations

¹ Department of Women's and Children's HealthKarolinska Institutet and Pediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden.
² Global Medical AffairsNovo Nordisk Health Care AG, Zurich, Switzerland.
³ EpidemiologyNovo Nordisk A/S, Søborg, Denmark.
⁴ Institute for Experimental Pediatric EndocrinologyCharité-University Medicine Berlin, Berlin, Germany.

PMID: 28159881
DOI: 10.1530/EJE-15-1017e

No abstract available

MeSH terms

Child
Female
Growth Disorders / drug therapy
Hormone Replacement Therapy / adverse effects
Hormone Replacement Therapy / standards*
Human Growth Hormone / therapeutic use*
Humans
Male
Observational Studies as Topic

Substances

Human Growth Hormone